grant
Positioning Mason's Regional Biocontainment Laboratory for Effective Pandemic Preparedness
Organization GEORGE MASON UNIVERSITYLocation FAIRFAX, UNITED STATESPosted 18 Aug 2023Deadline 31 Jul 2028
NIHUS FederalResearch GrantFY2025AccelerationAcuteAddressAlpha VirusAnimal Experimental UseAnimal ExperimentationAnimal ResearchApplied ResearchApplied ScienceBSL-3 facilityBSL3 facilityBasic ResearchBasic ScienceBiological TerrorismBiologyBiomedical ResearchBioterrorBioterrorismBody TissuesCOVID crisisCOVID epidemicCOVID pandemicCOVID-19 crisisCOVID-19 epidemicCOVID-19 eraCOVID-19 global health crisisCOVID-19 global pandemicCOVID-19 health crisisCOVID-19 pandemicCOVID-19 periodCOVID-19 public health crisisCOVID-19 yearsCapitalCertificationCollaborationsContainmentCoronaviridaeCoronavirusDataDevelopment and ResearchDiagnosticDisease OutbreaksEconomic BurdenEmerging Communicable DiseasesEmerging Infectious DiseasesEngineeringEnsureEnvironmentFaceFiloviridaeFilovirusFundingGroup A ArbovirusesHealthImmune responseIndividualInfectious AgentInfectious Diseases / LaboratoryInfectious Diseases ResearchInvestigatorsKnowledgeLaboratoriesLaboratory ResearchLeadershipLearningMaintenanceMentorshipModelingNIAIDNational Institute of Allergy and Infectious DiseaseOrganoidsOrthocoronavirinaeOutbreaksPathogenesisPositionPositioning AttributeR & DR&DRegulationResearchResearch InfrastructureResearch PersonnelResearch ResourcesResearchersResourcesSARS-CoV-2 epidemicSARS-CoV-2 global health crisisSARS-CoV-2 global pandemicSARS-CoV-2 pandemicSARS-coronavirus-2 epidemicSARS-coronavirus-2 pandemicSafetySecureServicesSevere Acute Respiratory Syndrome CoV 2 epidemicSevere Acute Respiratory Syndrome CoV 2 pandemicSevere acute respiratory syndrome coronavirus 2 epidemicSevere acute respiratory syndrome coronavirus 2 pandemicSystemTestingTherapeuticTissuesToxic effectToxicitiesTrainingTraining ProgramsTransmissionUniversitiesUpdateVaccinesViral DiseasesVirus Diseasesanimal experimentationsanimal imagingbiocontainment facilitybiocontainment labbiocontainment laboratorybiosafety level 3 facilitybuild resiliencebuild resiliencycorona viruscoronavirus disease 2019 crisiscoronavirus disease 2019 epidemiccoronavirus disease 2019 global health crisiscoronavirus disease 2019 global pandemiccoronavirus disease 2019 health crisiscoronavirus disease 2019 pandemiccoronavirus disease 2019 public health crisiscoronavirus disease crisiscoronavirus disease epidemiccoronavirus disease pandemiccoronavirus disease-19 global pandemiccoronavirus disease-19 pandemicdetermine efficacydevelop resiliencedevelop resiliencydrug discoveryefficacy analysisefficacy assessmentefficacy determinationefficacy evaluationefficacy examinationenhance resilienceenhance resiliencyevaluate efficacyexamine efficacyfacesfacialfacilitate resiliencefuture pandemicgood laboratory practicehost responseimmune system responseimmunoresponseimprove resilienceimprove resiliencyimprovedin vivoincrease resilienceincrease resiliencyinfectious organisminnovateinnovationinnovativelaboratory facilitylead optimizationmicrophysiologic modelmicrophysiologic platformmicrophysiologic systemmicrophysiology modelmicrophysiology platformmicrophysiology systemnext pandemicoperationoperationsorgan chiporgan on a chiporgan on chippandemic disease preparednesspandemic planningpandemic preparednesspandemic readinesspathogenpre-clinicalpre-clinical studypreclinicalpreclinical studyproduct developmentprogramspromote resiliencepromote resiliencyresearch and developmentresilience developmentresponsesafety assessmentsafety practicesevere acute respiratory syndrome coronavirus 2 global health crisissevere acute respiratory syndrome coronavirus 2 global pandemicsuccesstraining opportunitytransmission processviral infectionvirus infectionvirus-induced disease
Description preview
OVERALL CORE ABSTRACT
George Mason University (GMU) Biomedical Laboratory (BRL) is one of 12 Regional
Biocontainment Laboratories (RBLs) established through NIAID support in the early 2000s to
serve as Biosafety Level 3 (BSL-3) facilities to conduct cutting edge pathogen research and
serve as resources to rapidly address emerging infectious…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click